Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0000902664-20-002761

Director sold 2,000,000 shares at $40.00 ($80,000,000)

From the SEC's structured data for this filing

Trades in this filing

GOEL DAVID E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-07-20 Sale : show line 1 in the form −2,000,000 $40.00 $80,000,000 13,115,090 I
Open-market sales · 2,000,000 sh · avg $40.00 · $80,000,000
Loading xslF345X03/ownership.xml…